{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:43:01Z","timestamp":1790394181072,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T00:00:00Z","timestamp":1656547200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006637","name":"School of Pharmacy, University College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006637","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.ejmech.2022.114571","type":"journal-article","created":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T02:04:26Z","timestamp":1656381866000},"page":"114571","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Triazole-substituted phenylboronic acids as tunable lead inhibitors of KPC-2 antibiotic resistance"],"prefix":"10.1016","volume":"240","author":[{"given":"Jingyuan","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Stapleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Humberto","family":"Xavier-Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Schatzlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shozeb","family":"Haider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jess","family":"Healy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0253-911X","authenticated-orcid":false,"given":"Geoffrey","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2022.114571_bib1","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1128\/JCM.38.11.4086-4095.2000","article-title":"Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii","volume":"38","author":"Corbella","year":"2000","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ejmech.2022.114571_bib2","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1128\/AAC.45.4.1151-1161.2001","article-title":"Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae","volume":"45","author":"Yigit","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2022.114571_bib3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev.biochem.78.082907.145923","article-title":"Multidrug resistance in bacteria","volume":"78","author":"Nikaido","year":"2009","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ejmech.2022.114571_bib4","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/s41564-019-0492-8","article-title":"Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread","volume":"4","author":"David","year":"2019","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.ejmech.2022.114571_bib5","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41579-019-0159-8","article-title":"Interplay between \u03b2-lactamases and new \u03b2-lactamase inhibitors","volume":"17","author":"Bush","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2022.114571_bib6","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1038\/s41467-017-02339-w","article-title":"The mechanism of NDM-1-catalyzed carbapenem hydrolysis is distinct from that of penicillin or cephalosporin hydrolysis","volume":"8","author":"Feng","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2022.114571_bib7","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1128\/AAC.00693-09","article-title":"Inhibitor resistance in the KPC-2 beta-lactamase, a preeminent property of this class A beta-lactamase","volume":"54","author":"Papp-Wallace","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2022.114571_bib8","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1021\/acs.jmedchem.7b00158","article-title":"Molecular basis of substrate recognition and product release by the Klebsiella pneumoniae carbapenemase (KPC-2)","volume":"60","author":"Pemberton","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114571_bib9","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3389\/fmicb.2018.00622","article-title":"Exploring additional dimensions of complexity in inhibitor design for serine beta-lactamases: mechanistic and intra- and inter-molecular chemistry approaches","volume":"9","author":"van den Akker","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejmech.2022.114571_bib10","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1128\/CMR.00037-09","article-title":"Three decades of beta-lactamase inhibitors","volume":"23","author":"Drawz","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2022.114571_bib11","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1128\/AAC.00080-14","article-title":"Activities of ceftazidime and avibactam against beta-lactamase-producing Enterobacteriaceae in a hollow-fiber pharmacodynamic model","volume":"58","author":"Coleman","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2022.114571_bib12","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00528-17","article-title":"Klebsiella pneumoniae carbapenemase-2 (KPC-2), substitutions at ambler position Asp179, and resistance to ceftazidime-avibactam: unique antibiotic-resistant phenotypes emerge from beta-lactamase protein engineering","volume":"8","author":"Barnes","year":"2017","journal-title":"mBio"},{"key":"10.1016\/j.ejmech.2022.114571_bib13","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1128\/AAC.04406-14","article-title":"Variants of beta-lactamase KPC-2 that are resistant to inhibition by avibactam","volume":"59","author":"Papp-Wallace","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2022.114571_bib14","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00174-18","article-title":"Relebactam is a potent inhibitor of the KPC-2 beta-lactamase and restores imipenem susceptibility in KPC-producing enterobacteriaceae","volume":"62","author":"Papp-Wallace","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2022.114571_bib15","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00564-19","article-title":"Molecular basis of class A beta-lactamase inhibition by relebactam","volume":"63","author":"Tooke","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2022.114571_bib16","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1021\/acs.jmedchem.5b00127","article-title":"Discovery of a cyclic boronic acid beta-lactamase inhibitor (RPX7009) with utility vs class A serine carbapenemases","volume":"58","author":"Hecker","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114571_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12406","article-title":"Structural basis of metallo-beta-lactamase, serine-beta-lactamase and penicillin-binding protein inhibition by cyclic boronates","volume":"7","author":"Brem","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2022.114571_bib18","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02260-16","article-title":"Cyclic boronates inhibit all classes of beta-lactamases","volume":"61","author":"Cahill","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2022.114571_bib19","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01443-17","article-title":"Vaborbactam: spectrum of beta-lactamase inhibition and impact of resistance mechanisms on activity in enterobacteriaceae","volume":"61","author":"Lomovskaya","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2022.114571_bib20","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1021\/acs.jmedchem.9b01518","article-title":"Discovery of taniborbactam (VNRX-5133): a broad-spectrum serine- and metallo-beta-lactamase inhibitor for carbapenem-resistant bacterial infections","volume":"63","author":"Liu","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114571_bib21","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cbpa.2019.03.001","article-title":"Will morphing boron-based inhibitors beat the beta-lactamases?","volume":"50","author":"Krajnc","year":"2019","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.ejmech.2022.114571_bib22","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1021\/acsinfecdis.7b00243","article-title":"Game changers: new beta-lactamase inhibitor combinations targeting antibiotic resistance in gram-negative bacteria","volume":"4","author":"Bush","year":"2018","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2022.114571_bib23","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S1074-5521(01)00034-5","article-title":"Structure-based design and in-parallel synthesis of inhibitors of AmpC beta-lactamase","volume":"8","author":"Tondi","year":"2001","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2022.114571_bib24","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1021\/ja0288338","article-title":"Nanomolar inhibitors of AmpC beta-lactamase","volume":"125","author":"Morandi","year":"2003","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2022.114571_bib25","doi-asserted-by":"crossref","first-page":"7852","DOI":"10.1021\/jm101015z","article-title":"Design, synthesis, crystal structures, and antimicrobial activity of sulfonamide boronic acids as beta-lactamase inhibitors","volume":"53","author":"Eidam","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114571_bib26","doi-asserted-by":"crossref","first-page":"5445","DOI":"10.1021\/acs.jmedchem.5b00341","article-title":"Click chemistry in lead optimization of boronic acids as beta-lactamase inhibitors","volume":"58","author":"Caselli","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114571_bib27","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/pro.3100","article-title":"Exploring the potential of boronic acids as inhibitors of OXA-24\/40 beta-lactamase","volume":"26","author":"Werner","year":"2017","journal-title":"Protein Sci."},{"key":"10.1016\/j.ejmech.2022.114571_bib28","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.1021\/ja042850a","article-title":"Structure, function, and inhibition along the reaction coordinate of CTX-M beta-lactamases","volume":"127","author":"Chen","year":"2005","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2022.114571_bib29","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1128\/AAC.02641-15","article-title":"Boronic acid transition state inhibitors active against KPC and other class A beta-lactamases: structure-activity relationships as a guide to inhibitor design","volume":"60","author":"Rojas","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2022.114571_bib30","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1016\/j.bmc.2018.04.055","article-title":"Boronic acid inhibitors of the class A beta-lactamase KPC-2","volume":"26","author":"Zhou","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114571_bib31","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.1128\/AAC.05127-11","article-title":"Production of KPC-2 carbapenemase by an Escherichia coli clinical isolate belonging to the international ST131 clone","volume":"55","author":"Morris","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2022.114571_bib32","series-title":"Performance Standards for Antimicrobial Susceptibility Testing Supplement M100","author":"Wayne","year":"2018"},{"key":"10.1016\/j.ejmech.2022.114571_bib33","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1128\/AAC.06099-11","article-title":"Crystal structures of KPC-2 beta-lactamase in complex with 3-nitrophenyl boronic acid and the penam sulfone PSR-3-226","volume":"56","author":"Ke","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2022.114571_bib34","doi-asserted-by":"crossref","first-page":"11205","DOI":"10.1016\/j.tet.2004.08.051","article-title":"The relationship among pKa, pH, and binding constants in the interactions between boronic acids and diols\u2014it is not as simple as it appears","volume":"60","author":"Yan","year":"2004","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2022.114571_bib35","series-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically M07-A10","author":"Wayne","year":"2015"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422004731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422004731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:40:37Z","timestamp":1759329637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523422004731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":35,"alternative-id":["S0223523422004731"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114571","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Triazole-substituted phenylboronic acids as tunable lead inhibitors of KPC-2 antibiotic resistance","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114571","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"114571"}}